Skip to main content

Xos Inc

For the period ended Dec 31, 2023. Filed Mar 29, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 29, 2024

XOS$2.29-3.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows

(in thousands)

Years Ended December 31,
20232022
Operating Activities:
Net loss$(75,843)$(73,325)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation3,3142,065
Amortization of right-of-use assets1,5641,566
Amortization of debt discounts and issuance costs6,2012,577
Amortization of insurance premiums4,3531,338
Inventory (recoveries) write-downs(1,876)5,661
Impairment of assets held for sale1,591—
Change in fair value of derivative instruments(671)(14,184)
Change in fair value of earn-out shares liability(519)(28,682)
Net realized losses on marketable debt securities, available-for-sale91147
Stock-based compensation expense7,9065,222
Other non-cash items1341,368
Changes in operating assets and liabilities:
Accounts receivable(6,982)(4,942)
Inventories22,049(31,285)
Prepaid expenses and other current assets(4,244)6,413
Other assets(739)(1,093)
Accounts payable(133)(7,268)
Other liabilities4,5186,462
Net cash used in operating activities(39,286)(127,960)
Investing Activities:
Purchases of property and equipment(1,385)(14,113)
Proceeds from the disposal of assets held for sale1,295—
Proceeds from sales and maturities of marketable debt securities, available-for-sale50,72096,823
Net cash provided by investing activities50,63082,710
Financing Activities:
Proceeds from issuance of convertible notes—54,300
Debt issuance costs—(403)
Proceeds from short-term insurance financing note3,7703,627
Principal payment for short-term insurance financing note(4,832)(1,562)
Proceeds from equipment financing—6,312
Principal payment for equipment leases(3,026)(1,392)
Proceeds from stock option exercises86
Payments of prepayment premiums(1,640)—
Payments of convertible notes(32,800)—
Taxes paid related to net share settlement of stock-based awards(1,060)(449)
Proceeds from issuance of Common Stock under Standby Equity Purchase Agreement1,2014,310
Net cash (used in) provided by financing activities(38,379)64,749
Net (decrease) increase in cash, cash equivalents and restricted cash(27,035)19,499
Cash, cash equivalents and restricted cash, beginning of year38,67519,176
Cash, cash equivalents and restricted cash, end of year$11,640$38,675
Reconciliation of Cash, Cash Equivalents and Restricted Cash to Consolidated Balance Sheets:
Cash and cash equivalents$11,640$35,631
Restricted cash$—$3,044
Total cash, cash equivalents and restricted cash$11,640$38,675
Supplemental disclosure of cash flow information
Cash paid for interest$1,524$—
Supplemental disclosure of non-cash investing and financing activities
Purchase of property and equipment in accounts payable$7$42
Recognition of right-of-use asset and lease liabilities upon ASC 842 adoption$—$7,682
Right-of-use assets obtained in exchange for operating lease obligations$—$437
Conversion of interest payable on convertible notes$12$122
Conversion of convertible notes$200$2,000
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.